DEAF1, DEAF1 transcription factor, 10522

N. diseases: 156; N. variants: 13
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER
0.700 Biomarker disease GENOMICS_ENGLAND De novo and biallelic DEAF1 variants cause a phenotypic spectrum. 30923367 2019
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24
0.700 GeneticVariation disease CLINVAR Functional analysis of novel DEAF1 variants identified through clinical exome sequencing expands DEAF1-associated neurodevelopmental disorder (DAND) phenotype. 28940898 2017
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24
0.700 GeneticVariation disease CLINVAR Exome analysis of Smith-Magenis-like syndrome cohort identifies de novo likely pathogenic variants. 28213671 2017
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER
0.700 GeneticVariation disease CLINVAR Functional analysis of novel DEAF1 variants identified through clinical exome sequencing expands DEAF1-associated neurodevelopmental disorder (DAND) phenotype. 28940898 2017
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER
0.700 GeneticVariation disease CLINVAR Identification of a syndrome comprising microcephaly and intellectual disability but not white matter disease associated with a homozygous c.676C>T p.R226W DEAF1 mutation. 26834045 2016
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER
0.700 GeneticVariation disease CLINVAR Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy. 26795593 2016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24
0.700 Biomarker disease GENOMICS_ENGLAND Recessive DEAF1 mutation associates with autism, intellectual disability, basal ganglia dysfunction and epilepsy. 26048982 2015
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER
0.700 GermlineCausalMutation disease ORPHANET Recessive DEAF1 mutation associates with autism, intellectual disability, basal ganglia dysfunction and epilepsy. 26048982 2015
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24
0.700 GeneticVariation disease UNIPROT Mutations affecting the SAND domain of DEAF1 cause intellectual disability with severe speech impairment and behavioral problems. 24726472 2014
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER
0.700 GeneticVariation disease CLINVAR Novel homozygous DEAF1 variant suspected in causing white matter disease, intellectual disability, and microcephaly. 24668509 2014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24
0.700 GeneticVariation disease UNIPROT A de novo paradigm for mental retardation. 21076407 2010
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24
0.700 Biomarker disease GENOMICS_ENGLAND A de novo paradigm for mental retardation. 21076407 2010
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER
0.700 Biomarker disease GENOMICS_ENGLAND A de novo paradigm for mental retardation. 21076407 2010
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24
0.700 CausalMutation disease CLINVAR Ion channel variation causes epilepsies. 11690625 2001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24
0.700 Biomarker disease CTD_human
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24
0.700 Biomarker disease GENOMICS_ENGLAND
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER
0.700 Biomarker disease CTD_human
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.470 GeneticVariation group BEFREE Deleterious mutations within the DNA binding domain of the transcription factor deformed epidermal autoregulatory factor 1 (DEAF1) result in a phenotypic spectrum of neurodevelopmental disorders including intellectual disabilities and autism spectrum disorders. 31783086 2020
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.470 Biomarker group BEFREE Deformed epidermal autoregulatory factor-1 (DEAF1), a transcription factor essential for central nervous system and early embryonic development, has recently been implicated in a series of intellectual disability-related neurodevelopmental anomalies termed, in this study, as DEAF1-associated neurodevelopmental disorder (DAND). 28940898 2017
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.470 Biomarker group BEFREE Retinoic acid is crucial for early development of the central neural system, and DEAF1 is associated with intellectual disability. 26743651 2016
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.470 GeneticVariation group BEFREE Identification of a syndrome comprising microcephaly and intellectual disability but not white matter disease associated with a homozygous c.676C>T p.R226W DEAF1 mutation. 26834045 2016
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.470 GeneticVariation group BEFREE A recent report has shown dominant DEAF1 mutations to occur de novo in patients with intellectual disability. 26048982 2015
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.470 GeneticVariation group BEFREE Our results demonstrate that mutations in DEAF1 cause ID and behavioral problems, most likely as a result of impaired transcriptional regulation by DEAF1. 24726472 2014
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.470 GeneticVariation group BEFREE Mutations affecting the SAND domain of DEAF1 cause intellectual disability with severe speech impairment and behavioral problems Vulto-van Silfhout et al. 25091821 2014
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.470 Biomarker group CTD_human A de novo paradigm for mental retardation. 21076407 2010